ProPhase Labs Announces Special Meeting and Preliminary Proxy Filing

ProPhase Labs, Inc. (NASDAQ: PRPH) has announced a Special Meeting of Shareholders scheduled for August 29, 2025, to vote on proposals including an increase in authorized shares to 1 billion. This move aims to position the company to attract high-value structured transactions and industry-leading participants in the crypto treasury space. The company filed a Preliminary Proxy Statement with the SEC on July 28, 2025, detailing these proposals. ProPhase Labs is focused on innovation, rewarding talent, and creating shareholder value, with initiatives such as collecting $50 million from Covid accounts receivables, developing the BE-Smart™ esophageal cancer test, and exploring strategic alternatives for Nebula Genomics.